Alta Advisers Ltd bought a new position in shares of Johnson & Johnson (NYSE:JNJ – Get Rating) in the third quarter, HoldingsChannel reports. The firm bought 6,700 shares of the company’s stock, valued at approximately $1,095,000. Johnson & Johnson accounts for 0.7% of Alta Advisers Ltd’s investment portfolio, making the stock its 12th largest holding.
Several other large investors also recently modified their holdings of JNJ. Morton Brown Family Wealth LLC raised its holdings in Johnson & Johnson by 78.0% in the 2nd quarter. Morton Brown Family Wealth LLC now owns 178 shares of the company’s stock worth $32,000 after purchasing an additional 78 shares in the last quarter. Goodman Advisory Group LLC bought a new position in Johnson & Johnson in the second quarter worth about $39,000. Cardinal Capital Management Inc. lifted its holdings in Johnson & Johnson by 333.3% in the second quarter. Cardinal Capital Management Inc. now owns 260 shares of the company’s stock worth $46,000 after buying an additional 200 shares during the period. First Bank & Trust boosted its position in Johnson & Johnson by 69.6% during the 2nd quarter. First Bank & Trust now owns 380 shares of the company’s stock valued at $67,000 after acquiring an additional 156 shares in the last quarter. Finally, Heritage Wealth Management LLC purchased a new position in shares of Johnson & Johnson during the 2nd quarter worth approximately $84,000. 67.94% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts recently weighed in on the company. Barclays began coverage on Johnson & Johnson in a research report on Monday, October 17th. They set an “equal weight” rating and a $175.00 price target on the stock. StockNews.com assumed coverage on shares of Johnson & Johnson in a report on Wednesday, October 12th. They set a “strong-buy” rating on the stock. Citigroup increased their price target on shares of Johnson & Johnson from $198.00 to $205.00 and gave the stock a “buy” rating in a research note on Monday, December 12th. Credit Suisse Group initiated coverage on shares of Johnson & Johnson in a research note on Thursday, November 17th. They set a “neutral” rating and a $170.00 price objective on the stock. Finally, Sanford C. Bernstein decreased their target price on shares of Johnson & Johnson from $194.00 to $190.00 in a research note on Wednesday, October 19th. Seven research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Johnson & Johnson presently has a consensus rating of “Moderate Buy” and a consensus target price of $182.42.
Johnson & Johnson Trading Down 0.3 %
Shares of NYSE:JNJ opened at $173.43 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.43 and a quick ratio of 1.18. Johnson & Johnson has a 1 year low of $155.72 and a 1 year high of $186.69. The company has a market cap of $453.43 billion, a P/E ratio of 24.15, a PEG ratio of 3.28 and a beta of 0.56. The stock’s fifty day moving average price is $176.33 and its 200-day moving average price is $171.44.
Johnson & Johnson (NYSE:JNJ – Get Rating) last posted its earnings results on Tuesday, October 18th. The company reported $2.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.49 by $0.06. The business had revenue of $23.79 billion for the quarter, compared to analysts’ expectations of $23.44 billion. Johnson & Johnson had a net margin of 19.95% and a return on equity of 35.37%. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.60 EPS. Sell-side analysts expect that Johnson & Johnson will post 10.04 earnings per share for the current year.
Johnson & Johnson Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 7th. Shareholders of record on Tuesday, February 21st will be paid a dividend of $1.13 per share. The ex-dividend date is Friday, February 17th. This represents a $4.52 dividend on an annualized basis and a yield of 2.61%. Johnson & Johnson’s dividend payout ratio is presently 62.95%.
Johnson & Johnson Company Profile
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.
- Get a free copy of the StockNews.com research report on Johnson & Johnson (JNJ)
- $2,000 at Alphabet’s YouTube Purchase: You’d Be Up This Much.
- Michael Burry is Bearish on Stocks Again and Heres Why
- Don’t Miss These 2 Mid-Cap Techs That Broke Out Last Week
- Is Macau a Sinking Ship for Wynn Resorts?
- Why Warner Bros Discovery Is the S&P’s Hottest Stock
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.